← FDA Drug Approvals (Drugs@FDA)

ORAGRAFIN SODIUM

NDA · New Drug Application · Sponsor: BRACCO · Approved 1962-06-25

Drug application

FDA Application #

NDA012967

Application type

New Drug Application

Brand name

ORAGRAFIN SODIUM

Generic name

Ipodate Sodium

Active ingredients

IPODATE SODIUM

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

BRACCO

First approval

1962-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown